Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion

N L Gottlieb et al. Arthritis Rheum. 1974 Mar-Apr.

. 1974 Mar-Apr;17(2):171-83.

doi: 10.1002/art.1780170211.

No abstract available

Cited by

Remission-inducing drugs in rheumatoid arthritis.
Anastassiades TP. Anastassiades TP. Can Med Assoc J. 1980 Feb 23;122(4):405-15. Can Med Assoc J. 1980. PMID: 6768438 Free PMC article. Review.
Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.
Wallis WJ, Simkin PA. Wallis WJ, et al. Clin Pharmacokinet. 1983 Nov-Dec;8(6):496-522. doi: 10.2165/00003088-198308060-00002. Clin Pharmacokinet. 1983. PMID: 6360465 Review.
Oral gold for rheumatoid arthritis.
Wright V. Wright V. Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):858-9. doi: 10.1136/bmj.289.6449.858. Br Med J (Clin Res Ed). 1984. PMID: 6434113 Free PMC article. No abstract available.
Monitoring gold plasma levels in rheumatoid arthritis.
Lorber A. Lorber A. Clin Pharmacokinet. 1977 Mar-Apr;2(2):127-46. doi: 10.2165/00003088-197702020-00004. Clin Pharmacokinet. 1977. PMID: 324688 Review. No abstract available.
Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis.
Van den Ouweland FA, Gribnau FW, Tan Y, Van Ginneken CA, Van de Putte LB. Van den Ouweland FA, et al. Clin Pharmacokinet. 1986 Nov-Dec;11(6):511-5. doi: 10.2165/00003088-198611060-00007. Clin Pharmacokinet. 1986. PMID: 3802691 No abstract available.